Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CVL237
i
Other names:
CVL237, KA2237
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Convalife, Karus Therap
Drug class:
PI3Kδ inhibitor, PI3Kβ inhibitor
Related drugs:
‹
copanlisib (32)
idelalisib (29)
duvelisib (26)
umbralisib (8)
INCB50465 (6)
RP6530 (6)
AZD8835 (1)
BR101801 (1)
CB-006-3 (1)
linperlisib (1)
ACP-319 (0)
BGB-10188 (0)
HSB-510 (0)
SL-901 (0)
TQ-B3525 (0)
ZX-101A (0)
GS-9820 (0)
HMPL-689 (0)
SHC014748M (0)
INCB040093 (0)
IOA-244 (0)
ME-401 (0)
GSK2636771 (8)
AZD8186 (4)
AZD6482 (2)
TGX-221 (1)
copanlisib (32)
idelalisib (29)
duvelisib (26)
umbralisib (8)
INCB50465 (6)
RP6530 (6)
AZD8835 (1)
BR101801 (1)
CB-006-3 (1)
linperlisib (1)
ACP-319 (0)
BGB-10188 (0)
HSB-510 (0)
SL-901 (0)
TQ-B3525 (0)
ZX-101A (0)
GS-9820 (0)
HMPL-689 (0)
SHC014748M (0)
INCB040093 (0)
IOA-244 (0)
ME-401 (0)
GSK2636771 (8)
AZD8186 (4)
AZD6482 (2)
TGX-221 (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login